01 / Contract Profile
HHSO100201600026C Federal Contract Award
Agency code 7505
ADD THE DEFINITION OF "DISCONTINUED PROGRAM" TO SECTION 1.B; ADD LANGUAGE TO THE "ORAVANCE PROGRAM" DEFINITION THAT STATES THE REMOVAL OF FURTHER PROGRESSION OF S-743229 FROM THE PORTFOLIO ; AND UPDATE THE PERIODS OF PERFORMANCE I
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
HHSO100201600026C contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2016 | $32.00M | 1 | — |
| FY 2018 | $0 | 3 | −100.0% |
| FY 2019 | $20.00M | 1 | — |
| FY 2020 | $15.00M | 1 | −25.0% |
| FY 2021 | $15.00M | 1 | +0.0% |
| FY 2022 | $6.14M | 1 | −59.0% |
| FY 2023 | $0 | 1 | −100.0% |
| FY 2024 | $10.00M | 2 | — |
| FY 2025 | $0 | 1 | −100.0% |
| FY 2026 | $0 | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
MEDICINES COMPANY, THE
UEI ZCK2MH2VMA26 · CAGE 37CG9
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $98.14M | 13 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $98.14M | 13 | 100.0% |
08 / Place of Performance
Where is the work recorded?
PARSIPPANY, MORRIS, NEW JERSEY, UNITED STATES
ZIP 070544409
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Feb 20, 2026 | P00012 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Sep 26, 2025 | P00011 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Oct 18, 2024 | P00010 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Apr 22, 2024 | P00009 | $10.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Jun 21, 2023 | P00008 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Sep 29, 2022 | P00007 | $6.14M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Mar 31, 2021 | P00006 | $15.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Apr 22, 2020 | P00005 | $15.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Aug 13, 2019 | P00004 | $20.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Aug 23, 2018 | 3 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Aug 22, 2018 | 1 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Aug 22, 2018 | 2 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
| Sep 15, 2016 | Base action | $32.00M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541711 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.